Milan, Italy, and Morristown, NJ, USA, August 12, 2025, 07:00 am CEST – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback